GSK plc's latest marketcap:
As of 07/04/2025, GSK plc's market capitalization has reached $77.02 B. According to our data, GSK plc is the 276th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 77.02 B |
| Revenue (ttm) | 40.74 B |
| Net Income (ttm) | 4.07 B |
| Shares Out | 4.08 B |
| EPS (ttm) | 0.98 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 05/16/2025 |
| Earnings Date | 07/30/2025 |
GSK plc's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/04/2025 | $77.02 B | 14.79% | 276 |
| 12/31/2024 | $68.57 B | -8.74% | 274 |
| 12/29/2023 | $75.14 B | 6.12% | 206 |
| 12/30/2022 | $70.81 B | -35.88% | 192 |
| 12/31/2021 | $110.43 B | 20.28% | 138 |
| 12/31/2020 | $91.81 B | -21.29% | 145 |
| 12/31/2019 | $116.64 B | 23.14% | 88 |
| 12/31/2018 | $94.72 B | 8.77% | 80 |
| 12/29/2017 | $87.08 B | -7.13% | 110 |
| 12/30/2016 | $93.77 B | -4.44% | 73 |
Company Profile
About GSK plc
GSK plc, together with its subsidiaries, is a global healthcare company specializing in the research, development, and manufacturing of vaccines and medicines to prevent and treat diseases. Headquartered in London, United Kingdom, GSK operates internationally with a strong presence in the UK and the US.
Business Segments
- Commercial Operations – Focuses on the distribution and sales of vaccines and medicines.
- Total R&D – Drives innovation through research and development of new treatments and vaccines.
Key Products
- Vaccines: Shingles, meningitis, respiratory syncytial virus (RSV), infectious diseases, polio, influenza, and pandemic vaccines.
- Specialty Medicines: Treatments for HIV, oncology, respiratory/immunology, and inflammatory conditions.
- General Medicines: Inhaled therapies for asthma and COPD, as well as antibiotics for infections.
Strategic Collaborations
- Partnership with CureVac to develop vaccines for influenza and COVID-19.
- Collaboration with Flagship Pioneering to discover novel medicines and vaccines.
Company Background
Originally founded in 1715 as GlaxoSmithKline plc, the company rebranded to GSK plc in May 2022. With a legacy spanning over three centuries, GSK remains a leader in global healthcare innovation.
Frequently Asked Questions
-
What is GSK plc's (GSK) current market cap?As of 07/04/2025, GSK plc (including the parent company, if applicable) has an estimated market capitalization of $77.02 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does GSK plc (GSK) rank globally by market cap?GSK plc global market capitalization ranking is approximately 276 as of 07/04/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.